Get in fist and sell product first - has to be the best strategy...

First 120 Last

Share
Profile

Follow
Footmax

15,569 Posts.

2786

14/01/22

10:58

Post #: 58859131
Share

Get in fist and sell product first - has to be the best strategy one would think.

Leases have still to be paid and it is wasted money while there are no holes in the ground.

Any future mergers, CR's or even take overs are better placed with a higher SP. BNL just needs to actually do something to get it at a higher level.

Originally posted by Jazzaborg: ↑

No sense of urgency! The jv with the others that will help keep things ticking a long but the level of motivation and speed of profress can rightly be questioned. We dont really have any other similar companies in the exact same boat but id bet my blue star holding they've done a lot f k n more in the past 12 months.
a shame because there really is so much potential here the list goes on and on and the location itself being so close to California silicon valley etc high end users yet at the end of the day you can have the best team in the world but if the coaches are on a different trip all your left with is potential. They've done some good things and very happy to be proven wrong but this whole give us millions of shares for doing sweet f k all has changed some of our sentiment and thats fair enough.

i understand the sp has performed well but lets be honeat its gone from the low to as high as low 5s in late 2020 all on potential. We dont have the team to thank for that thats a bit of a luck and again that POTENTIAL

this year could be make or break for a lot of holders and there literal bnl holdings

Expand

BNL Price at posting: 5.9¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 120 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.5¢		Change -0.001(9.09%)		Mkt cap ! $14.82M

Open	High	Low	Value	Volume
0.5¢	0.6¢	0.5¢	$32.35K	6.433M

Buyers (Bids)

No.	Vol.	Price($)
23	20550660	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	2436187	4

View Market Depth

No.	Vol.	Price($)
23	20550660	0.004
9	15476669	0.003
6	20032500	0.002
4	27405000	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	2450270	4
0.006	3074481	10
0.007	7056658	16
0.008	12112729	27
0.009	3930033	11

Last trade - 12.24pm 27/06/2025 (20 minute delay)

BNL (ASX) Chart

Get in fist and sell product first - has to be the best strategy...

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Get in fist and sell product first - has to be the best strategy...

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News